Healthetech, Inc. SMART Study

计划入组 56 人 · 首次发布于 2005 年 9 月 19 日

Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

计划入组 12 人 · 首次发布于 2016 年 10 月 28 日

Clinical Evaluation and Assesment of Ginigivitis Patients Treated by Yarrow Natural Extract in Compare to a Contro Group

计划入组 40 人 · 首次发布于 2023 年 10 月 6 日

Pain therapeutic(Cypress Bioscience, Inc.)

Recombinant gastric lipase(Ventria Bioscience, Inc.)

Antibody drug conjugate (Chiome Bioscience, Inc.)

Ipsen Bioscience, Inc.

United States

NEUROTROPE BIOSCIENCE INC

United States

SKYE BIOSCIENCE INC

United States

GenSci Partners with RTW Investments in $1.365 Billion Deal for First-in-Class Thyroid Autoimmune Disease Therapy

VYNE Therapeutics and Yarrow Bioscience Merger Nears Completion: Cash Dividend Distributed, Reverse Stock Split Set, and YB-101 Poised to Advance Autoimmune Thyroid Disease Pipeline

Skye Bioscience Advances Nimacimab into Phase 2 Obesity Trial